Loading…

The requirement of GnRH at the beginning of the five-day CO-Synch + controlled internal drug release protocol in beef heifers

The objective of this study was to determine if the omission of GnRH at controlled internal drug release device (CIDR) insertion would impact pregnancy rates to timed AI (TAI) in beef heifers enrolled in a 5-d CO-Synch + CIDR protocol that used 1 PGF2α dose given at CIDR removal. Yearling beef heife...

Full description

Saved in:
Bibliographic Details
Published in:Journal of animal science 2014-09, Vol.92 (9), p.4198-4203
Main Authors: Cruppe, L H, Day, M L, Abreu, F M, Kruse, S, Lake, S L, Biehl, M V, Cipriano, R S, Mussard, M L, Bridges, G A
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 4203
container_issue 9
container_start_page 4198
container_title Journal of animal science
container_volume 92
creator Cruppe, L H
Day, M L
Abreu, F M
Kruse, S
Lake, S L
Biehl, M V
Cipriano, R S
Mussard, M L
Bridges, G A
description The objective of this study was to determine if the omission of GnRH at controlled internal drug release device (CIDR) insertion would impact pregnancy rates to timed AI (TAI) in beef heifers enrolled in a 5-d CO-Synch + CIDR protocol that used 1 PGF2α dose given at CIDR removal. Yearling beef heifers in Ohio in 2 consecutive breeding seasons (2011, n = 151, and 2012, n = 143; Angus × Simmental), Utah (2012, n = 265; Angus × Hereford), Idaho (2012, n = 127; Charolais), and Wyoming (2012, n = 137; Angus) were enrolled in the 5-d CO-Synch + CIDR protocol. At CIDR insertion (d -5), heifers were randomly assigned either to receive 100 μg GnRH (GnRH+; n = 408) or not to receive GnRH (GnRH-; n = 415). At CIDR removal (d 0 of the experiment), 25 mg PGF2α was administered to all heifers. All heifers were inseminated by TAI and given 100 μg GnRH 72 h after PGF2α (d 3). In heifers at the Ohio locations (n = 294), presence of a corpus luteum (CL) at CIDR insertion (d -5) was determined via assessment of progesterone concentrations (2011) and ovarian ultrasonography (2012). Subsequently, in both years, ovarian ultrasound was conducted on d 0 to determine the presence of a new CL. In this same subgroup of heifers, blood samples for progesterone analysis were collected on d 3 to assess luteal regression. Pregnancy diagnosis was performed between 32 and 38 d after TAI. At CIDR withdrawal, presence of a new CL was greater (P < 0.05) in the GnRH+ (55.8%, 82/147) than GnRH- (26.5%, 39/147) treatment. Incidence of failed luteal regression did not differ between the GnRH+ (3.4%) and GnRH- (0.7%) treatments. Pregnancy rate to TAI did not differ between the GnRH+ (50.5%) and GnRH- (54.9%) treatments. In conclusion, although the incidence of a new CL at CIDR removal was increased in the GnRH+ treatment, omission of the initial GnRH treatment in the 5-d CO-Synch + CIDR protocol did not influence TAI pregnancy rate in yearling beef heifers. In addition, a single dose of PGF2α at CIDR removal was effective at inducing luteolysis in yearling beef heifers enrolled in the 5-d CO-Synch + CIDR protocol, regardless of whether or not the initial GnRH treatment was given.
doi_str_mv 10.2527/jas.2014-7772
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1560578750</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1560578750</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-1e5bfedef7a3fb6328313bd8ea1e55346b0979d0e4cebbb5f3fa522cf3f42ba43</originalsourceid><addsrcrecordid>eNo1kE1LAzEURYMgtlaXbiVLQabmYzJpl1K0FQoFreshmXlpU9JMm2SELvzvRqyrC-9cDo-L0B0lYyaYfNqpOGaEloWUkl2gIRVMFJxWfICuY9wRQpmYiis0YIIISbgYou_1FnCAY28D7MEn3Bk89-8LrBJOGWnYWO-t3_yC34OxX1C06oRnq-Lj5JstfsRN51PonIMWW58geOVwG_pNFjtQEfAhdKlrOpdxNoLBW7AGQrxBl0a5CLfnHKHP15f1bFEsV_O32fOyOFBWpYKC0AZaMFJxoyvOJpxy3U5AZSJ4WWkyldOWQNmA1loYbpRgrMlZMq1KPkIPf978yLGHmOq9jQ04pzx0faypqPIgEylIrt6fq73eQ1sfgt2rcKr_J-M_BB9tSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1560578750</pqid></control><display><type>article</type><title>The requirement of GnRH at the beginning of the five-day CO-Synch + controlled internal drug release protocol in beef heifers</title><source>Oxford Journals Online</source><creator>Cruppe, L H ; Day, M L ; Abreu, F M ; Kruse, S ; Lake, S L ; Biehl, M V ; Cipriano, R S ; Mussard, M L ; Bridges, G A</creator><creatorcontrib>Cruppe, L H ; Day, M L ; Abreu, F M ; Kruse, S ; Lake, S L ; Biehl, M V ; Cipriano, R S ; Mussard, M L ; Bridges, G A</creatorcontrib><description>The objective of this study was to determine if the omission of GnRH at controlled internal drug release device (CIDR) insertion would impact pregnancy rates to timed AI (TAI) in beef heifers enrolled in a 5-d CO-Synch + CIDR protocol that used 1 PGF2α dose given at CIDR removal. Yearling beef heifers in Ohio in 2 consecutive breeding seasons (2011, n = 151, and 2012, n = 143; Angus × Simmental), Utah (2012, n = 265; Angus × Hereford), Idaho (2012, n = 127; Charolais), and Wyoming (2012, n = 137; Angus) were enrolled in the 5-d CO-Synch + CIDR protocol. At CIDR insertion (d -5), heifers were randomly assigned either to receive 100 μg GnRH (GnRH+; n = 408) or not to receive GnRH (GnRH-; n = 415). At CIDR removal (d 0 of the experiment), 25 mg PGF2α was administered to all heifers. All heifers were inseminated by TAI and given 100 μg GnRH 72 h after PGF2α (d 3). In heifers at the Ohio locations (n = 294), presence of a corpus luteum (CL) at CIDR insertion (d -5) was determined via assessment of progesterone concentrations (2011) and ovarian ultrasonography (2012). Subsequently, in both years, ovarian ultrasound was conducted on d 0 to determine the presence of a new CL. In this same subgroup of heifers, blood samples for progesterone analysis were collected on d 3 to assess luteal regression. Pregnancy diagnosis was performed between 32 and 38 d after TAI. At CIDR withdrawal, presence of a new CL was greater (P &lt; 0.05) in the GnRH+ (55.8%, 82/147) than GnRH- (26.5%, 39/147) treatment. Incidence of failed luteal regression did not differ between the GnRH+ (3.4%) and GnRH- (0.7%) treatments. Pregnancy rate to TAI did not differ between the GnRH+ (50.5%) and GnRH- (54.9%) treatments. In conclusion, although the incidence of a new CL at CIDR removal was increased in the GnRH+ treatment, omission of the initial GnRH treatment in the 5-d CO-Synch + CIDR protocol did not influence TAI pregnancy rate in yearling beef heifers. In addition, a single dose of PGF2α at CIDR removal was effective at inducing luteolysis in yearling beef heifers enrolled in the 5-d CO-Synch + CIDR protocol, regardless of whether or not the initial GnRH treatment was given.</description><identifier>EISSN: 1525-3163</identifier><identifier>DOI: 10.2527/jas.2014-7772</identifier><identifier>PMID: 25057035</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Breeding - methods ; Cattle ; Delayed-Action Preparations - administration &amp; dosage ; Delayed-Action Preparations - pharmacology ; Dinoprost - pharmacology ; Estrus Synchronization - methods ; Female ; Gonadotropin-Releasing Hormone - administration &amp; dosage ; Gonadotropin-Releasing Hormone - pharmacology ; Insemination, Artificial - methods ; Insemination, Artificial - veterinary ; Luteolysis - drug effects ; Ovary - diagnostic imaging ; Ovary - drug effects ; Pregnancy ; Pregnancy Rate ; Progesterone - blood ; Ultrasonography ; United States</subject><ispartof>Journal of animal science, 2014-09, Vol.92 (9), p.4198-4203</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25057035$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cruppe, L H</creatorcontrib><creatorcontrib>Day, M L</creatorcontrib><creatorcontrib>Abreu, F M</creatorcontrib><creatorcontrib>Kruse, S</creatorcontrib><creatorcontrib>Lake, S L</creatorcontrib><creatorcontrib>Biehl, M V</creatorcontrib><creatorcontrib>Cipriano, R S</creatorcontrib><creatorcontrib>Mussard, M L</creatorcontrib><creatorcontrib>Bridges, G A</creatorcontrib><title>The requirement of GnRH at the beginning of the five-day CO-Synch + controlled internal drug release protocol in beef heifers</title><title>Journal of animal science</title><addtitle>J Anim Sci</addtitle><description>The objective of this study was to determine if the omission of GnRH at controlled internal drug release device (CIDR) insertion would impact pregnancy rates to timed AI (TAI) in beef heifers enrolled in a 5-d CO-Synch + CIDR protocol that used 1 PGF2α dose given at CIDR removal. Yearling beef heifers in Ohio in 2 consecutive breeding seasons (2011, n = 151, and 2012, n = 143; Angus × Simmental), Utah (2012, n = 265; Angus × Hereford), Idaho (2012, n = 127; Charolais), and Wyoming (2012, n = 137; Angus) were enrolled in the 5-d CO-Synch + CIDR protocol. At CIDR insertion (d -5), heifers were randomly assigned either to receive 100 μg GnRH (GnRH+; n = 408) or not to receive GnRH (GnRH-; n = 415). At CIDR removal (d 0 of the experiment), 25 mg PGF2α was administered to all heifers. All heifers were inseminated by TAI and given 100 μg GnRH 72 h after PGF2α (d 3). In heifers at the Ohio locations (n = 294), presence of a corpus luteum (CL) at CIDR insertion (d -5) was determined via assessment of progesterone concentrations (2011) and ovarian ultrasonography (2012). Subsequently, in both years, ovarian ultrasound was conducted on d 0 to determine the presence of a new CL. In this same subgroup of heifers, blood samples for progesterone analysis were collected on d 3 to assess luteal regression. Pregnancy diagnosis was performed between 32 and 38 d after TAI. At CIDR withdrawal, presence of a new CL was greater (P &lt; 0.05) in the GnRH+ (55.8%, 82/147) than GnRH- (26.5%, 39/147) treatment. Incidence of failed luteal regression did not differ between the GnRH+ (3.4%) and GnRH- (0.7%) treatments. Pregnancy rate to TAI did not differ between the GnRH+ (50.5%) and GnRH- (54.9%) treatments. In conclusion, although the incidence of a new CL at CIDR removal was increased in the GnRH+ treatment, omission of the initial GnRH treatment in the 5-d CO-Synch + CIDR protocol did not influence TAI pregnancy rate in yearling beef heifers. In addition, a single dose of PGF2α at CIDR removal was effective at inducing luteolysis in yearling beef heifers enrolled in the 5-d CO-Synch + CIDR protocol, regardless of whether or not the initial GnRH treatment was given.</description><subject>Animals</subject><subject>Breeding - methods</subject><subject>Cattle</subject><subject>Delayed-Action Preparations - administration &amp; dosage</subject><subject>Delayed-Action Preparations - pharmacology</subject><subject>Dinoprost - pharmacology</subject><subject>Estrus Synchronization - methods</subject><subject>Female</subject><subject>Gonadotropin-Releasing Hormone - administration &amp; dosage</subject><subject>Gonadotropin-Releasing Hormone - pharmacology</subject><subject>Insemination, Artificial - methods</subject><subject>Insemination, Artificial - veterinary</subject><subject>Luteolysis - drug effects</subject><subject>Ovary - diagnostic imaging</subject><subject>Ovary - drug effects</subject><subject>Pregnancy</subject><subject>Pregnancy Rate</subject><subject>Progesterone - blood</subject><subject>Ultrasonography</subject><subject>United States</subject><issn>1525-3163</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo1kE1LAzEURYMgtlaXbiVLQabmYzJpl1K0FQoFreshmXlpU9JMm2SELvzvRqyrC-9cDo-L0B0lYyaYfNqpOGaEloWUkl2gIRVMFJxWfICuY9wRQpmYiis0YIIISbgYou_1FnCAY28D7MEn3Bk89-8LrBJOGWnYWO-t3_yC34OxX1C06oRnq-Lj5JstfsRN51PonIMWW58geOVwG_pNFjtQEfAhdKlrOpdxNoLBW7AGQrxBl0a5CLfnHKHP15f1bFEsV_O32fOyOFBWpYKC0AZaMFJxoyvOJpxy3U5AZSJ4WWkyldOWQNmA1loYbpRgrMlZMq1KPkIPf978yLGHmOq9jQ04pzx0faypqPIgEylIrt6fq73eQ1sfgt2rcKr_J-M_BB9tSw</recordid><startdate>201409</startdate><enddate>201409</enddate><creator>Cruppe, L H</creator><creator>Day, M L</creator><creator>Abreu, F M</creator><creator>Kruse, S</creator><creator>Lake, S L</creator><creator>Biehl, M V</creator><creator>Cipriano, R S</creator><creator>Mussard, M L</creator><creator>Bridges, G A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201409</creationdate><title>The requirement of GnRH at the beginning of the five-day CO-Synch + controlled internal drug release protocol in beef heifers</title><author>Cruppe, L H ; Day, M L ; Abreu, F M ; Kruse, S ; Lake, S L ; Biehl, M V ; Cipriano, R S ; Mussard, M L ; Bridges, G A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-1e5bfedef7a3fb6328313bd8ea1e55346b0979d0e4cebbb5f3fa522cf3f42ba43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Breeding - methods</topic><topic>Cattle</topic><topic>Delayed-Action Preparations - administration &amp; dosage</topic><topic>Delayed-Action Preparations - pharmacology</topic><topic>Dinoprost - pharmacology</topic><topic>Estrus Synchronization - methods</topic><topic>Female</topic><topic>Gonadotropin-Releasing Hormone - administration &amp; dosage</topic><topic>Gonadotropin-Releasing Hormone - pharmacology</topic><topic>Insemination, Artificial - methods</topic><topic>Insemination, Artificial - veterinary</topic><topic>Luteolysis - drug effects</topic><topic>Ovary - diagnostic imaging</topic><topic>Ovary - drug effects</topic><topic>Pregnancy</topic><topic>Pregnancy Rate</topic><topic>Progesterone - blood</topic><topic>Ultrasonography</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cruppe, L H</creatorcontrib><creatorcontrib>Day, M L</creatorcontrib><creatorcontrib>Abreu, F M</creatorcontrib><creatorcontrib>Kruse, S</creatorcontrib><creatorcontrib>Lake, S L</creatorcontrib><creatorcontrib>Biehl, M V</creatorcontrib><creatorcontrib>Cipriano, R S</creatorcontrib><creatorcontrib>Mussard, M L</creatorcontrib><creatorcontrib>Bridges, G A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of animal science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cruppe, L H</au><au>Day, M L</au><au>Abreu, F M</au><au>Kruse, S</au><au>Lake, S L</au><au>Biehl, M V</au><au>Cipriano, R S</au><au>Mussard, M L</au><au>Bridges, G A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The requirement of GnRH at the beginning of the five-day CO-Synch + controlled internal drug release protocol in beef heifers</atitle><jtitle>Journal of animal science</jtitle><addtitle>J Anim Sci</addtitle><date>2014-09</date><risdate>2014</risdate><volume>92</volume><issue>9</issue><spage>4198</spage><epage>4203</epage><pages>4198-4203</pages><eissn>1525-3163</eissn><abstract>The objective of this study was to determine if the omission of GnRH at controlled internal drug release device (CIDR) insertion would impact pregnancy rates to timed AI (TAI) in beef heifers enrolled in a 5-d CO-Synch + CIDR protocol that used 1 PGF2α dose given at CIDR removal. Yearling beef heifers in Ohio in 2 consecutive breeding seasons (2011, n = 151, and 2012, n = 143; Angus × Simmental), Utah (2012, n = 265; Angus × Hereford), Idaho (2012, n = 127; Charolais), and Wyoming (2012, n = 137; Angus) were enrolled in the 5-d CO-Synch + CIDR protocol. At CIDR insertion (d -5), heifers were randomly assigned either to receive 100 μg GnRH (GnRH+; n = 408) or not to receive GnRH (GnRH-; n = 415). At CIDR removal (d 0 of the experiment), 25 mg PGF2α was administered to all heifers. All heifers were inseminated by TAI and given 100 μg GnRH 72 h after PGF2α (d 3). In heifers at the Ohio locations (n = 294), presence of a corpus luteum (CL) at CIDR insertion (d -5) was determined via assessment of progesterone concentrations (2011) and ovarian ultrasonography (2012). Subsequently, in both years, ovarian ultrasound was conducted on d 0 to determine the presence of a new CL. In this same subgroup of heifers, blood samples for progesterone analysis were collected on d 3 to assess luteal regression. Pregnancy diagnosis was performed between 32 and 38 d after TAI. At CIDR withdrawal, presence of a new CL was greater (P &lt; 0.05) in the GnRH+ (55.8%, 82/147) than GnRH- (26.5%, 39/147) treatment. Incidence of failed luteal regression did not differ between the GnRH+ (3.4%) and GnRH- (0.7%) treatments. Pregnancy rate to TAI did not differ between the GnRH+ (50.5%) and GnRH- (54.9%) treatments. In conclusion, although the incidence of a new CL at CIDR removal was increased in the GnRH+ treatment, omission of the initial GnRH treatment in the 5-d CO-Synch + CIDR protocol did not influence TAI pregnancy rate in yearling beef heifers. In addition, a single dose of PGF2α at CIDR removal was effective at inducing luteolysis in yearling beef heifers enrolled in the 5-d CO-Synch + CIDR protocol, regardless of whether or not the initial GnRH treatment was given.</abstract><cop>United States</cop><pmid>25057035</pmid><doi>10.2527/jas.2014-7772</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1525-3163
ispartof Journal of animal science, 2014-09, Vol.92 (9), p.4198-4203
issn 1525-3163
language eng
recordid cdi_proquest_miscellaneous_1560578750
source Oxford Journals Online
subjects Animals
Breeding - methods
Cattle
Delayed-Action Preparations - administration & dosage
Delayed-Action Preparations - pharmacology
Dinoprost - pharmacology
Estrus Synchronization - methods
Female
Gonadotropin-Releasing Hormone - administration & dosage
Gonadotropin-Releasing Hormone - pharmacology
Insemination, Artificial - methods
Insemination, Artificial - veterinary
Luteolysis - drug effects
Ovary - diagnostic imaging
Ovary - drug effects
Pregnancy
Pregnancy Rate
Progesterone - blood
Ultrasonography
United States
title The requirement of GnRH at the beginning of the five-day CO-Synch + controlled internal drug release protocol in beef heifers
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A50%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20requirement%20of%20GnRH%20at%20the%20beginning%20of%20the%20five-day%20CO-Synch%20+%20controlled%20internal%20drug%20release%20protocol%20in%20beef%20heifers&rft.jtitle=Journal%20of%20animal%20science&rft.au=Cruppe,%20L%20H&rft.date=2014-09&rft.volume=92&rft.issue=9&rft.spage=4198&rft.epage=4203&rft.pages=4198-4203&rft.eissn=1525-3163&rft_id=info:doi/10.2527/jas.2014-7772&rft_dat=%3Cproquest_pubme%3E1560578750%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p126t-1e5bfedef7a3fb6328313bd8ea1e55346b0979d0e4cebbb5f3fa522cf3f42ba43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1560578750&rft_id=info:pmid/25057035&rfr_iscdi=true